| Application no. and date | 13760943.4 (espacenet) (Federated) (European Patent Register), 20130301 | | Patent/reg. no. and date | DK/EP 2819667, 20191225 | | Publication date | 20150107 | | Priority no. and date | US 201261605729 P, 20120301, US 201261642212 P, 20120503, US 201261644360 P, 20120508 | | EP pub. no. and date |
EP 2819667 20150107 | | Effective date | | | Applicant/owner | Retinagenix Therapeutics, Inc., 421 Kipling Street
Palo Alto, California 94301, US | | Applicant ref. no. | 1546197 | | Inventor | CADDEN, Suzanne, 4211 Sunset Blvd.
North Vancouver, British Columbia V7R 3Y7, CA | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/232 (2006.01) , A61P 27/02 (2006.01) | | Title | RETINALDERIVATER TIL ANVENDELSE TIL FORBEDRING AF SYNSFUNKTIONEN | | Int. application no. | CA2013050155 | | Int. publication no. | WO2013134867 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
